Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students

Acute Stroke Clinical Trial

Official title:

Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students and Evaluation of the Efficiency of Simulation Method in the Development of Self-Efficacy Proficiency Levels

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05462665
• Other study ID #: tPA Treatment
• Status: Completed
• Phase: N/A
• Start date: May 1, 2020
• Est. completion date: March 1, 2022

Study information

• Verified date: December 2021
• Source: Dokuz Eylul University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.

Description:

Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: March 1, 2022
• Est. primary completion date: March 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

Intern nursing student at Dokuz Eylül University

Exclusion Criteria:

Those who did not agree to participate in the study Those who were not be intern

Related Conditions & MeSH terms

• Acute Stroke
• Stroke

Intervention

Behavioral:
• theory training
theory training
• theory and simulation training
theory and simulation training

Locations

Country	Name	City	State
Turkey	Ozge Soydaner	Izmir

Sponsors (1)

Lead Sponsor	Collaborator
Dokuz Eylul University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	self-efficacy scale	Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after theoric teaching	Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention
Primary	simulation scale	evaluation the simulation design	2 weeks after simulation training
Primary	tPA treatment information form	Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after simulation and theoric teaching	Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention